New research from CPI reveals systemic barriers facing UK MedTech startups and spinouts and calls for co-ordinated reform across regulation, investment and NHS adoption, to unlock innovation and deliver national health and economic strategies.
CPI, a leading translational research and innovation organisation, has published three interconnected reports offering a comprehensive analysis of the challenges facing UK MedTech innovators. Drawing on insights from 240 small and medium-sized enterprises (SMEs), 40 investors and 10 university technology transfer offices, the reports spell out the solutions needed to unlock the full potential of UK MedTech and deliver on the promises of the healthcare and life science sectors.
Central to the NHS 10-Year Health Plan and the Life Sciences Sector Plan, both released in July 2025, is adoption of cutting-edge medical technologies. However, UK-based MedTech innovators say they face too many barriers with funding and regulatory hurdles, especially compared to the funding and regulatory ecosystems for MedTech innovation in the United States.
Rahul Kapoor, Director of HealthTech at CPI, said: "The life sciences sector, including medical devices, diagnostics and pharmaceuticals, is a priority sector for the UK and a significant economic driver. Achieving the 10-year plan requires access to funding for rapid development and reducing barriers to adoption of life saving technologies."
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
